Novartis | NOVN - Interest Income


Novartis reported $6M in Interest Income for its fiscal quarter ending in March of 2024.





Interest Income Change Date
AbbVie USD 59M 13M Dec/2025
Almirall EUR 2.71M 580K Dec/2025
AstraZeneca USD 73M 62M Mar/2026
Autolus Therapeutics Ltd USD 6.14M 1.31M Mar/2025
Bayer EUR 169M 39M Dec/2025
Biogen USD 37.9M 700K Mar/2026
Eli Lilly USD 65M 25M Sep/2025
Fresenius Medical Care EUR 14.62M 999K Mar/2026
Genmab DKK 25M 8M Jun/2025
Gilead Sciences USD 95M 7M Dec/2025
GlaxoSmithKline GBP 22M 96M Mar/2026
GRIFOLS EUR 9.56M 4.5M Jun/2025
Hikma Pharmaceutical USD 4M 0 Dec/2024
J&J USD 2.14 237M Mar/2026
Lakefront Biotherapeutics EUR 13.56M 991K Mar/2026
Merck EUR 21M 6M Dec/2025
Merck USD 69M 27M Dec/2025
Pfizer USD 115M 51M Mar/2026
Philips EUR 8M 13M Dec/2025
Regeneron Pharmaceuticals USD 193.3M 18.2M Dec/2025
Sanofi EUR 33M 81M Dec/2025